(Q73593551)
English
A randomized phase II trial comparing two different sequence combinations of autologous vaccine and human recombinant interferon gamma and human recombinant interferon alpha2B therapy in patients with metastatic renal cell carcinoma: clinical outcom
scientific article published on 01 April 2000
Statements
A randomized phase II trial comparing two different sequence combinations of autologous vaccine and human recombinant interferon gamma and human recombinant interferon alpha2B therapy in patients with metastatic renal cell carcinoma: clinical outcome and analysis of immunological parameters (English)
T Schwaab
J A Heaney
A R Schned
R D Harris
B F Cole
R J Noelle
D M Phillips
L Stempkowski